News & Updates
Filter by Specialty:
Lebrikizumab helps clear skin of teens with moderate-to-severe atopic dermatitis
12 Apr 2023
byStephen Padilla
Treatment with lebrikizumab with or without topical corticosteroids (TCS) results in clinical improvement among adolescents with moderate-to-severe atopic dermatitis (AD), according to a study presented at the recent AAD 2023.